Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
MVV Energie AG | MVV1 | 8. oct 2024 | 31.00 | -0.64 |
MWB FAIRTRADE WPHDL.NA ON | MWB0 | 8. oct 2024 | 3.13 | -3.10 |
Mycronic | MLT | 8. oct 2024 | 32.04 | -5.71 |
Mydecine Innovations Group Inc | 0NF0 | 8. oct 2024 | 0.00 | -14.29 |
Myer Holdings Ltd | 30M | 8. oct 2024 | 0.49 | -0.81 |
Myers Industries, Inc. | MJF | 8. oct 2024 | 11.50 | +0.88 |
MYHEALTHCHECKED LS -,015 | 0I10 | 8. oct 2024 | 0.13 | -13.25 |
MYHOTELMATCH EO 1,- | 6GD0 | 8. oct 2024 | 0.36 | +0.28 |
Mynaric ADR | M0YA | 8. oct 2024 | 1.33 | +3.10 |
MYNARIC AG NA O.N. | M0YN | 8. oct 2024 | 5.24 | -4.73 |
Mynd.Ai | WK6 | 8. oct 2024 | 0.63 | +7.69 |
Myomo Inc. | 0M61 | 8. oct 2024 | 3.40 | -5.56 |
MYR Group, Inc. | MYP | 8. oct 2024 | 97.50 | +3.17 |
Myriad Genetics, Inc. | MYD | 8. oct 2024 | 23.60 | -1.67 |
MYRIAD URANIUM CORP. | C3Q | 8. oct 2024 | 0.21 | -1.85 |
Mytilineos S.A. | MYH | 8. oct 2024 | 33.52 | +0.66 |
N Brown Group PLC | BGUA | 8. oct 2024 | 0.31 | +2.67 |
N4 Pharma plc. | 0GO | 8. oct 2024 | 0.00 | 0.00 |
Naas Technology ADR | 6RE | 8. oct 2024 | 3.42 | -6.04 |
Nabaltec AG | NTG | 8. oct 2024 | 15.10 | +1.00 |
Nabors Industries Ltd | NBI1 | 8. oct 2024 | 69.50 | -6.08 |
Nabtesco Corp. | 3N8 | 8. oct 2024 | 15.30 | -1.29 |
Nachi-Fujikoshi Corp. | 8UM | 8. oct 2024 | 19.60 | -1.01 |
Nacon S.A. | 4AW | 8. oct 2024 | 0.79 | -4.36 |
Nafco Co | 64E | 8. oct 2024 | 14.60 | -0.68 |
NAGACORP | N9J | 8. oct 2024 | 0.42 | -7.44 |
Nagambie Resources Limited | P6C | 8. oct 2024 | 0.00 | -18.18 |
Nagarro SE | NA9 | 8. oct 2024 | 92.00 | -2.90 |
Nagoya Railroad Co. Ltd | 59V | 8. oct 2024 | 10.30 | -0.96 |
Nakanishi Inc. | 6SN | 8. oct 2024 | 16.30 | -0.61 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.